about
Natural Inhibitors of Snake Venom Metalloendopeptidases: History and Current ChallengesA review on the strategies for oral delivery of proteins and peptides and their clinical perspectivesA Review of the Latest Advances in Encrypted Bioactive Peptides from Protein-Rich WasteLanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionFrom Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide ToxinsAnti-parasitic Peptides from Arthropods and their Application in Drug TherapySynthetic Peptides as Protein MimicsRecent Advances Toward the Discovery of Drug-Like Peptides De novoTargeting the Eph System with Peptides and Peptide ConjugatesDepot-Based Delivery Systems for Pro-Angiogenic Peptides: A ReviewAutomated solid-phase peptide synthesis to obtain therapeutic peptidesStructure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activityPEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesThe cyclic cystine ladder of theta-defensins as a stable, bifunctional scaffold: A proof-of-concept study using the integrin-binding RGD motifAnticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targetingTransforming conotoxins into cyclotides: Backbone cyclization of P-superfamily conotoxinsOxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL ProteaseConstraining an Irregular Peptide Secondary Structure through Ring-Closing Alkyne MetathesisAccurate de novo design of hyperstable constrained peptidesTotal chemical synthesis, refolding, and crystallographic structure of fully active immunophilin calstabin 2 (FKBP12.6)Natural structural diversity within a conserved cyclic peptide scaffoldOral Delivery of Protein Drugs Bioencapsulated in Plant CellsMotif mediated protein-protein interactions as drug targetsNatural antimicrobial peptides against Mycobacterium tuberculosisUnlocking the secrets to protein-protein interface drug targets using structural mass spectrometry techniquesThe E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6DnaK as Antibiotic Target: Hot Spot Residues Analysis for Differential Inhibition of the Bacterial Protein in Comparison with the Human HSP70Detection of Peptide-based nanoparticles in blood plasma by ELISAScalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional ChemotherapeuticsSynthesis and Evaluation of Biological Activity of Antimicrobial--Pro-Proliferative Peptide ConjugatesNovel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational ModificationsInvestigation of Elemental Mass Spectrometry in Pharmacology for Peptide Quantitation at Femtomolar LevelsHigh-throughput expression of animal venom toxins in Escherichia coli to generate a large library of oxidized disulphide-reticulated peptides for drug discoveryPEPlife: A Repository of the Half-life of PeptidesChemical Platform for the Preparation of Synthetic Orally Active Peptidomimetics with Hemoregulating ActivityEvaluation of the use of therapeutic peptides for cancer treatmentDirect Activation of Bax Protein for Cancer TherapyProtein folding and de novo protein design for biotechnological applicationsForcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family.Constraining cyclic peptides to mimic protein structure motifs.
P2860
Q26738414-29931F84-7383-4E5C-862A-D6F89E57F138Q26744008-BF9A03A7-1D05-4C23-B2E0-5C506F304FA6Q26744366-2C97583A-2ADA-4CA1-A1BF-A442326971DDQ26748638-BB72CDE3-BCB8-4D02-8B23-339B353ADCD4Q26750941-8CAE825C-5671-4A5D-BFD8-893076EAB52BQ26768112-473346A9-B466-41A9-A039-C2B7C0A01A59Q26770255-3E90E5F2-BDCA-44E5-8089-C1551D804C05Q26770535-E4597939-79F5-4258-A062-BA8573F25F4CQ26799461-83BC9A92-D5C1-4189-B2A0-F44E35CD48E6Q26799856-C8E9CBB0-BCBD-4DCD-A354-0DA275805A0AQ27001623-10537EF9-E63F-4865-B9F9-AF44916F344CQ27021886-B7A841E9-DBB2-4334-BD69-1AC4824A792FQ27026916-92B295F5-0E97-47B7-93AA-A1DEA1152F60Q27688055-E64698D3-6BA7-496C-A80B-00935F7FA3BEQ27694726-F1D27DD9-8748-4681-AD37-D0ED5F26D2F2Q27701553-B2252A0E-D852-4D79-ACC0-C4CB522BBFCAQ27703748-19A3EBD9-A0B0-4E2A-9A6B-DF92BD6454F7Q27728007-381DB54E-BDC5-4C83-AEDC-6E4D38413BA8Q27728065-C43CD97B-C628-4EAF-A55B-6FC319FCDB70Q27728121-34AF3BD4-6C4A-4AC7-881E-25097FA54902Q27728164-066EF149-ECF6-4687-BC53-43B314376511Q28079063-1AC4027F-EEEF-4C29-83C2-59638A0A62F5Q28079554-C327259F-E772-4516-B0BD-3D6D5B348ABEQ28082317-A2261A09-7DB4-48C7-BC44-B14D5D1AF8B2Q28087729-D0E4C0B7-EC82-45CA-8D8D-67C08E78EE54Q28544832-776410FB-A0EF-4FB3-8405-7637156BBFFEQ28546662-0E72FA2E-C693-4258-B1E4-07E07EE245FDQ28547412-4255254F-0E2E-4656-9860-8DBBF9620CE9Q28548620-57FECE09-FC5F-43E4-B0C9-AD1DFC0CFC81Q28550329-110DCE28-8FE0-4FDF-8149-3C40FDF97516Q28550956-AD093D0D-7A1F-4AEE-BC11-C011B2AA1239Q28552043-82687DCE-B12F-4B73-8AC3-0CBEC054A7EAQ28816920-9399F5E2-B43F-4B9E-A1FB-9F27F1780B98Q28821997-269C621B-4741-4B58-802E-469CEC37DC57Q28822160-9EF682F0-E3E1-44B1-B847-D86E336263F1Q29048586-169D7518-BFD7-4869-98D8-7F05F5C92CE5Q30353924-F4954DFA-F05B-4BDC-ADD2-8948A7458F85Q30355936-75343449-D701-4520-A0CF-79DB4496A901Q30363657-8B872426-8CB7-4A35-89EB-708D0388789CQ30367509-C646A14E-504B-4D46-BE71-C5F4DC2C0029
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The future of peptide-based drugs
@ast
The future of peptide-based drugs
@en
The future of peptide-based drugs
@nl
type
label
The future of peptide-based drugs
@ast
The future of peptide-based drugs
@en
The future of peptide-based drugs
@nl
prefLabel
The future of peptide-based drugs
@ast
The future of peptide-based drugs
@en
The future of peptide-based drugs
@nl
P3181
P356
P1476
The future of peptide-based drugs
@en
P2093
David Price
Spiros Liras
P304
P3181
P356
10.1111/CBDD.12055
P407
P577
2013-01-01T00:00:00Z